SCHEMBL14340635

SCHEMBL14340635

CC(C)c1cc(C2(C)CC2)cc(C#N)c1[S+](C)[O-]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13688747 0.78 — —
SCHEMBL13690271 0.74 P2RX3 (0.31) —
SCHEMBL13843660 0.72 — —
SCHEMBL13748290 0.65 AR (0.31) —
SCHEMBL19117423 0.65 AR (0.33) —
SCHEMBL16122428 0.60 PGR (0.33) —
SCHEMBL18135456 0.59 MAOA (0.38) —
SCHEMBL2153709 0.59 GABRA1 (0.37) —
SCHEMBL14340660 0.58 ALOX5 (0.38) —
SCHEMBL13688750 0.58 GABRA1 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1867646-A1 Cytokine inhibitors Boehringer Ingelheim Pharmaceuticals, Inc. (US) 2007-12-19 — — EP disclosed
Send feedback